David B. Musket, Director at CAPRICOR THERAPEUTICS, INC. (CAPR), bought 70,962 shares at $3.52 ($250K) on 2015-01-21, disclosed to the SEC on 2015-01-22.
Open-market purchase of $250k CAPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CAPR | BUY | 2023-10-06 | $7K | — | Filing → |
| CAPR | SELL | 2022-07-01 | $213K | — | Filing → |
| CAPR | SELL | 2022-06-29 | $79K | — | Filing → |